Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force

✍ Scribed by Vellas, Bruno; Carrillo, Maria C.; Sampaio, Cristina; Brashear, H. Robert; Siemers, Eric; Hampel, Harald; Schneider, Lon S.; Weiner, Michael; Doody, Rachelle; Khachaturian, Zaven; Cedarbaum, Jesse; Grundman, Michael; Broich, Karl; Giacobini, Ezio; Dubois, Bruno; Sperling, Reisa; Wilcock, Gordon K.; Fox, Nick; Scheltens, Philip; Touchon, Jacques; Hendrix, Suzanne; Andrieu, Sandrine; Aisen, Paul

• Book ID: 123350680
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 625 KB
• Volume: 9
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2013.03.007